Form 4: Director Eric Major Receives Sanara MedTech Stock Grant
Director Equity Grant
Sanara MedTech Inc. director Eric D. Major was granted 4,846 shares of restricted common stock under the company's 2024 Omnibus Long-Term Incentive Plan.
Summary
- Director Eric D. Major acquired 4,846 shares of Sanara MedTech Inc. (SMTI) common stock.
- The shares were granted as restricted stock under the 2024 Omnibus Long-Term Incentive Plan.
- Following this transaction, the reporting person's total beneficial ownership is 14,232 shares.
- The grant was issued at a price of $0 per share.
Sentiment
Score: 5
Explanation: StockSavvy.ai views this as a routine administrative filing regarding director compensation, which is neutral in terms of immediate market impact.
Positives
- Alignment of director interests with long-term shareholder value through equity-based compensation.
Negatives
- None identified.
Risks
- Vesting of the restricted stock is contingent upon the director providing continued services to the issuer through the vesting date.
Future Outlook
The restricted stock is scheduled to vest on the earlier of the 2027 annual shareholder meeting or June 4, 2027, subject to continued service.
Industry Context
StockSavvy.ai notes that equity grants to directors are standard corporate governance practices designed to incentivize long-term strategic oversight and align leadership with shareholder interests in the medical technology sector.
Comparison to Industry Standards
- The use of an Omnibus Long-Term Incentive Plan is consistent with standard executive and director compensation practices among small-cap medical device companies.
- Vesting periods of approximately one year for director equity grants are common practice to ensure retention and commitment.
Stakeholder Impact
- Shareholders: Minimal impact, as this represents standard director compensation.
Next Steps
- Vesting of the 4,846 shares on or before June 4, 2027.
Key Dates
| Date | Description |
|---|---|
| 06/04/2026 | Date of the restricted stock grant transaction. |
| 06/05/2026 | Date of filing for the Form 4. |
| 06/04/2027 | Vesting date for the restricted stock grant. |
Keywords
Sanara MedTech, SMTI, Form 4, Insider Transaction, Equity Compensation, Director Ownership
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.